source
- STAT+: Big drugmakers tell House committee they will halt clinical trials at some hospitals in ChinaBig drugmakers tell U.S. House committee they will halt clinical trials at some hospitals in China.STAT · 1h ago↗ source
- Congressional biotech panel cautions on rising China licensing dealsA bipartisan congressional commission that advises on U.S. biotech competitiveness is concluding its work with a focus on partnerships with Chinese firms. The panel highlighted the growing number…